Graduate Program in Health Sciences and Technologies, Faculty of Ceilândia - University of Brasilia, Federal District, Brasilia, Brazil.
Department of Science and Technology, Ministry of Health, Federal District, Brasilia, Brazil.
PLoS Negl Trop Dis. 2023 Mar 16;17(3):e0011134. doi: 10.1371/journal.pntd.0011134. eCollection 2023 Mar.
Neglected tropical diseases are a global public health problem. Although Brazil is largely responsible for their occurrence in Latin America, research funding on the subject does not meet the population's health needs. The present study analyzed the evolution of research funding for neglected tropical diseases by the Ministry of Health and its partners in Brazil, from 2004 to 2020. This is a retrospective study of data from investigations registered on Health Research (Pesquisa Saúde in Portuguese), a public repository for research funded by the Ministry of Health's Department of Science and Technology. The temporal trend of funding and the influence of federal government changes on funding were analyzed using Prais-Winster generalized linear regression. From 2004 to 2020, 1,158 studies were financed (purchasing power parity (PPP$) 230.9 million), with most funding aimed at biomedical research (81.6%) and topics involving dengue, leishmaniasis and tuberculosis (60.2%). Funding was stationary (annual percent change of -5.7%; 95%CI -54.0 to 45.0) and influenced by changes to the federal government. Research funding was lacking for chikungunya, Chagas disease, schistosomiasis, malaria and taeniasis/cysticercosis, diseases with a high prevalence, burden or mortality rates in Brazil. Although the Ministry of Health had several budgetary partners, it was the main funder, with 69.8% of investments. The study revealed that research funding for neglected tropical diseases has stagnated over the years and that diseases with a high prevalence, burden and mortality rate receive little funding. These findings demonstrate the need to strengthen the health research system by providing sustainable funding for research on neglected tropical diseases that is consistent with the population's health needs.
被忽视的热带病是全球公共卫生问题。尽管巴西在很大程度上对拉丁美洲的这些疾病负责,但针对这些疾病的研究资金无法满足人口的健康需求。本研究分析了 2004 年至 2020 年期间,巴西卫生部及其合作伙伴对被忽视的热带病的研究资金演变情况。这是一项对卫生部科学技术司资助的健康研究(葡萄牙语为 Pesquisa Saúde)注册调查数据进行的回顾性研究。使用 Prais-Winster 广义线性回归分析了资金的时间趋势以及联邦政府变化对资金的影响。2004 年至 2020 年,共资助了 1158 项研究(购买力平价(PPP$)2.309 亿美元),其中大部分资金用于生物医学研究(81.6%)和涉及登革热、利什曼病和结核病的研究(60.2%)。资金处于停滞状态(年变化率为-5.7%;95%CI-54.0 至 45.0),并受到联邦政府变化的影响。巴西流行率、负担或死亡率较高的基孔肯雅热、恰加斯病、血吸虫病、疟疾和带绦虫病/囊尾蚴病等疾病缺乏研究资金。尽管卫生部有几个预算伙伴,但它是主要的资金提供者,投资占 69.8%。研究表明,多年来,被忽视的热带病研究资金已经停滞不前,而流行率、负担和死亡率较高的疾病得到的资金很少。这些发现表明,需要通过为与人口健康需求一致的被忽视的热带病研究提供可持续资金来加强卫生研究系统。